IHS Chemical Week

Cytec beats estimates as sales rise slightly

11:09 AM MDT | October 18, 2013

Cytec has reported third-quarter net earnings of $43.8 million, or $1.19/share, down 25% year-on-year (YOY), with sales from continuing operations totaling $464 million, up 2%. Excluding charges and discontinued operations, adjusted earnings from continuing operations totaled $49.4 million, or $1.34/share, up 6% and slightly ahead of analysts’ consensus estimate of $1.32/share, as reported by Thomson Reuters (New York). “Our third quarter results reflect more modest top line growth compared to the third quarter of last year as legacy large commercial aircraft...

Access is for Chemweek 24/7 PLUS Members ONLY

This information is only available to Chemweek 24/7 PLUS members who have subscribed to Chemweek’s Business Daily. If you are a member, please log in, OR if you have a trial membership, please use your trial membership account information. 

Username:
Password:

Forgot your user ID or password? Click here to have it sent to you.

 

 

If you are not yet a subscriber and would like to access the turnkey information found only in Chemweek’s Business Daily, subscribe now and you’ll get the most important news of the chemical industry delivered directly to your inbox—every day.

Sign up for a FREE 15-day trial of IHS Chemical Week Business Daily













 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2012 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa